JOINT FILING AGREEMENT OF Ampersand 1999 Limited Partnership Ampersand 2001 Limited Partnership AMP-99 Management Company Limited Liability Company AMP-01 Management Company Limited Liability Company
Exhibit
99.1
Exhibit
1
Ampersand
1999 Limited Partnership
Ampersand
2001 Limited Partnership
AMP-99
Management Company Limited Liability Company
AMP-01
Management Company Limited Liability Company
The undersigned persons agree and
consent pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
as amended, as of the date set forth below, to the joint filing on their behalf
of the Schedule 13G, including any and all amendment thereto, to which this
Exhibit is attached, in connection with their beneficial ownership of the common
stock of Talecris Biotherapeutics Holdings Corp. at December 31, 2009 and agree
that such statement is filed on behalf of each of them.
| AMP-99 Management Company Limited Liability Company | |||
|
|
By:
|
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |
|
▇▇▇▇▇▇▇
▇. ▇▇▇▇▇▇▇, Principal Managing Member
Dated:
February 16, 2010
|
|||
| Ampersand 1999 Limited Partnership | |||
| By: | AMP-99 Management Company Limited Liability Company, its General Partner | ||
|
|
By:
|
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |
|
▇▇▇▇▇▇▇
▇. ▇▇▇▇▇▇▇, Principal Managing Member
Dated:
February 16, 2010
|
|||
| AMP-01 Management Company Limited Liability Company | |||
|
|
By:
|
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |
|
▇▇▇▇▇▇▇
▇. ▇▇▇▇▇▇▇, Principal Managing Member
Dated:
February 16, 2010
|
|||
| Ampersand 2001 Limited Partnership | |||
| By: |
AMP-01
Management Company Limited Liability Company, its General
Partner
|
||
|
|
By:
|
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |
|
▇▇▇▇▇▇▇
▇. ▇▇▇▇▇▇▇, Principal Managing Member
Dated:
February 16, 2010
|
|||